Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Westinghouse Electric Company is a global leader in nuclear energy technology that plays a pivotal role in the healthcare sector as a primary producer of medical isotopes. The company utilizes its nuclear reactor technology and engineering capabilities to manufacture Cobalt-60, which is essential for the sterilization of medical equipment and for use in Gamma Knife cancer treatments. Additionally, Westinghouse has expanded its footprint in nuclear medicine through the production of Lutetium-177, a critical isotope for targeted radioligand therapies in oncology. By securing the supply chain for these high-demand isotopes, Westinghouse supports the development and delivery of advanced diagnostic and therapeutic procedures worldwide. The company operates as a key infrastructure partner for the radiopharmaceutical industry, bridging the gap between nuclear physics and clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Westinghouse Electric.